A Clinical Trial to study effects of tofacitinib and oral mini pulse(betamethasone) in moderate to very severe alopecia areata patients
Phase 3
- Conditions
- Health Condition 1: L63- Alopecia areata
- Registration Number
- CTRI/2023/09/057476
- Lead Sponsor
- Arun Achar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient willing to give consent.
2.18-70 years old.
3.Moderate to very severe alopecia areata -according to SALT Score as below
SALT SCORESEVERITY OF AA
0%No Hair Loss
1-20%Limited
21-49% Moderate
50-94% Severe
95-100%Very Severe
Exclusion Criteria
1.Pregnancy and lactation.
2.Patients with uncontrolled liver, renal, cardiovascular, hematological or connective tissue disorders.
3.Contraindication to oral tofacitinib or oral steroid.
4.Patients received systemic treatment within 1 month before presenting to our Out Patient Department.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method